BIO

Bio-Rad Laboratories Inc

Price

$364.26

return (12m)

26.32%

p/e

13.82

p/bv

1.34

DIVIDEND YIELD

0.00%

BIO price

Bio-Rad Laboratories Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

22.08%

3 months

27.03%

1 year

26.32%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals BIO

Valuation

P/E

13.82

Sector 7.79

Industry 7.79

P/BV

1.34

Sector 2.11

Industry 2.11

P/Revenue (PSR)

3.72

Sector 2.22

Industry 2.22

EV/EBITDA

Sector -156.98

Industry -156.98

EV/EBIT

Sector -1,355,776,171.42

Industry -1,355,776,171.42

P/EBITDA

-21.96

Sector 2.51

Industry 2.51

P/EBIT

-20.09

Sector 0.34

Industry 0.34

P/Total Assets

0.94

Sector 1.00

Industry 1.00

P/Net Current Assets

-167.30

Sector -3.84

Industry -3.84

P/Working Capital

4.68

Sector -5,077.26

Industry -5,077.26

EPS

26.01

Sector 0.67

Industry 0.67

BVPS

267.54

Sector 10.17

Industry 10.17

Efficiency

Gross Margin

51.90%

Sector 32.61%

Industry 32.61%

EBITDA Margin

Sector -284.80%

Industry -284.80%

EBIT Margin

0.00%

Sector -4.02%

Industry -4.02%

Operating Margin

9.06%

Sector 4.45%

Industry 4.45%

Net Profit Margins

26.94%

Sector 2.39%

Industry 2.39%

Asset Turnover

0.06

Sector 0.11

Industry 0.11

Profitability

ROE

9.72%

Sector 2.05%

Industry 2.05%

ROA

6.80%

Sector -0.90%

Industry -0.90%

ROIC

Sector -118.95%

Industry -118.95%

Dividends

Dividend yield

0.00%

Sector 0.60%

Industry 0.60%

Payout

0.00%

Sector 11.53%

Industry 11.53%

Debt

Current Ratio

3.14

Sector 1.44

Industry 1.44

Net Debt / EBITDA

Sector -39,522,158.34

Industry -39,522,158.34

Net Debt / EBIT

Sector -31.03

Industry -31.03

Net Debt / Equity

Sector -0.72

Industry -0.72

Gross Debt / Equity

Sector 0.21

Industry 0.21

Equity/Assets

0.70

Sector 0.43

Industry 0.43

Liabilities/Assets

0.30

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

-2.39%

Sector -

Industry -

5Y Earnings CAGR

-30.32%

Sector -

Industry -

FAIR VALUE OF Bio-Rad Laboratories Inc ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$364.26

Fair Value

$395.69

Upside Return potential.

8.63%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals BIO

DRAG THE FRAME TO SEE MORE DATA

BIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Bio-Rad Laboratories Inc (United States) is listed on the Nasdaq and has a market capitalization of $9.64 billion, with shareholders equity totaling $7.17 billion.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Bio-Rad Laboratories Inc reported $2.59 billion in revenue, generating net income of $697.50 million.

Key financial metrics include a P/E ratio of 13.82, a price-to-book (P/B) ratio of 1.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BIO.

Market cap

$9.64 billion

Net worth

$7.17 billion

$7,173,900,000.00

Assets

$10.25 billion

$10,252,000,000.00

Total Shares Outstanding

26.81 million

26,814,000

Average Daily Trading Volume

$411.53 Thousand

$411,526.00

Sector

Others

Industry

Others

BIO

BIO revenue and profits

Financial Results BIO

DRAG THE FRAME TO SEE MORE DATA

BIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.61 33,84% (12M)

P/E

25.58

2.23%

ROE

13.33%

P/BV

3.41

SHEL - Shell PLC ADR

$92.77 34,82% (12M)

P/E

9.65

3.30%

ROE

14.29%

P/BV

1.38

STLA - Stellantis NV

$5.43 --44,42% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$317.10 5,40% (12M)

P/E

22.86

0.76%

ROE

81.04%

P/BV

18.52

SSNLF - Samsung Electronics Co Ltd

$- -0,00% (12M)

P/E

13.54

4.85%

ROE

1.69%

P/BV

0.23

ALIZY - Allianz SE ADR

$51.08 --13,60% (12M)

P/E

14.12

2.66%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.07 54,62% (12M)

P/E

7.06

4.61%

ROE

21.42%

P/BV

1.51

NSRGY - Nestle SA ADR

$99.21 9,18% (12M)

P/E

11.98

4.01%

ROE

58.05%

P/BV

6.96